Ann R Coll Surg Engl 2007; 89: 490-493 490Haemangioma is the commonest benign liver tumour with an incidence of 0.4-7.3% in autopsy series. 1 With the increasing use of imaging modalities, asymptomatic giant haemangiomas (> 4 cm in size) are detected more frequently. These lesions can, at times, present a diagnostic dilemma.
2There is considerable controversy regarding the ideal treatment of giant haemangiomas of the liver. Some authors, on the basis of long-term follow-up of such lesions, propose that most of these lesions do not require any treatment. 3,4 Others have treated these lesions surgically, citing symptoms of the patient, increase in size and an occasional case of rupture, or diagnostic uncertainty.
5The surgical procedure is the choice of the individual surgeon -the commonest being enucleation and resection. 5,6 Massive blood loss can occur during surgery and may result in an operative mortality. Though liver resections can be safely accomplished in specialised units, occasional postoperative complications (bile leak) do occur. Enucleation may represent a safer surgical option with fewer complications for the treatment of haemangiomas, especially in centres with limited experience in liver resections.We reviewed our experience of the surgical treatment of giant haemangiomas of the liver with regard to presentation, indications and outcome. We also compared our results with those published in the literature.
Patients and MethodsThe details of all patients undergoing surgical treatment of liver haemangiomas at the Department of Gastrointestinal There is continuing debate regarding the ideal method of surgical treatment for liver haemangiomas, with some surgeons favouring enucleation over liver resection.